Leap Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...
Source: prnewswire.com